Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 29, 2015 1:13 AM ET

Capital Markets

Company Overview of AbbVie Biotech Ventures, Inc.

Company Overview

AbbVie Biotech Ventures, Inc. is a venture capital arm of AbbVie Inc. specializing in early stage investments. It seeks to invest in emerging biotech and pharmaceutical companies with a focus on neuroscience, immunology, cardiology, virology, and oncology. The firm also invests in programs ranging from pre-clinical, which is 18 months prior to first-in-human to early proof-of-concept. It seeks to syndicate with other venture capital firms and participate as a follow-on investor. The firm also seeks to lead the investments, take a board seat, and act as a minority investor. AbbVie Biotech Ventures, Inc. is based in North Chicago, Illinois.

100 Abbott Park Road

Abbott Park

North Chicago, IL 60064-3500

United States

Phone:

847-937-6100

Key Executives for AbbVie Biotech Ventures, Inc.

Vice President and Managing Director
Senior Director
Senior Director
Compensation as of Fiscal Year 2014.

AbbVie Biotech Ventures, Inc. Key Developments

AbbVie Biotech Ventures, Inc. Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 09:15 AM

AbbVie Biotech Ventures, Inc. Presents at 8th Annual EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION, Mar-03-2015 09:15 AM. Venue: Hilton, Zurich Airport Hotel, Hohenbuehlstrasse 10, Opfikon-Glattbrugg 8152 Zurich, Zurich, Switzerland. Speakers: Margarita I. Chavez, Director.

AbbVie Biotech Ventures, Inc. Presents at 13th Annual BIO Investor Forum, Oct-08-2014 03:30 PM

AbbVie Biotech Ventures, Inc. Presents at 13th Annual BIO Investor Forum, Oct-08-2014 03:30 PM. Venue: The Palace Hotel, San Francisco, CA 94105, United States. Speakers: David Donabedian, Vice President.

AbbVie Biotech Ventures, Inc. Presents at The 9th annual New England Venture Summit, Dec-10-2014 04:30 PM

AbbVie Biotech Ventures, Inc. Presents at The 9th annual New England Venture Summit, Dec-10-2014 04:30 PM. Venue: Hilton Boston Dedham, 25 Allied Drive, Dedham, MA 02026, United States. Speakers: David Donabedian, Vice President.

Similar Private Companies By Industry

Company Name Region
FORE Holdings Liquidating Trust United States
Thorpe Capital Group, LLC United States
CMS Resource Development Company United States
Henley & Company LLC United States
The DAK Group, Ltd. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
September 11, 2014
AM-Pharma B.V.
Private Placement
April 16, 2014
Kala Pharmaceuticals, Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AbbVie Biotech Ventures, Inc., please visit www.abbviebiotechventures.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.